Author:
Iizuka Yusuke,Katagiri Tomohiro,Ogura Kengo,Inoue Minoru,Nakashima Ryota,Nakamura Kiyonao,Mizowaki Takashi
Abstract
AbstractThis study aimed to assess recurrence-free survival (RFS) rates and recurrence-related factors of patients who received adjuvant therapy (AT) with radioactive iodine (RAI) for differentiated thyroid cancer (DTC) following thyroidectomy. We evaluated 284 patients who underwent AT between January 2011 and July 2020 at our hospital. Recurrence was defined as visible recurrent lesions on image analysis or need for repeat surgery with pathologically confirmed recurrent lesions. RFS rate and prognostic factors were statistically evaluated. The median observation period was 30.2 months (range, 5.7–294 months). Overall, 192 patients were female and 92 were male, and the median age was 54 years (range, 9–85 years). Initial assessment revealed 39 recurrence cases. The 3-year RFS rate was 85.8% (95% confidence interval: 81.1–90.9%). Univariate analysis revealed that histology (except for papillary carcinoma), Tg level > 4 ng/dL before AT, and AT result significantly exacerbated the RFS rate. In multivariate analysis, histology and AT result were also important contributors to the worsening RFS rate. Results of AT can be determined relatively early and are important in predicting future recurrence in patients with DTC. Increasing the success rate of AT may lead to an improved prognosis.
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Vigneri, R., Malandrino, P. & Vigneri, P. The changing epidemiology of thyroid cancer: Why is incidence increasing?. Curr. Opin. Oncol. 27, 1–7. https://doi.org/10.1097/CCO.0000000000000148 (2015).
2. National Cancer Center Cancer Information Service. https://ganjoho.jp/public/index.html (2019).
3. Hori, M. et al. Cancer incidence and incidence rates in Japan in 2009: A study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol. 45, 884–891. https://doi.org/10.1093/jjco/hyv088 (2015).
4. Sawka, A. M. et al. American Thyroid Association guidelines and statements: Past, present, and future. Thyroid 28, 692–706. https://doi.org/10.1089/thy.2018.0070 (2018).
5. The Japanese Society of Thyroid Surgery/The Japan Association of Endocrine Surgeons. Guidelines for the management of thyroid tumors. J. Jpn. Assoc. Endocr. Surg. Jpn. Soc. Thyroid Surg. 35, Suppl 3 (2018).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献